Literature DB >> 21786738

[Diabetes plans in six European countries and in Canada].

Laurence Fond-Harmant1.   

Abstract

Seventeen of the 27 European Union countries have established programs and initiatives to counteract the increasing rate of diabetes in Europe. Luxembourg has not instituted such an initiative at a national level but is considering a national scheme. This article presents several national diabetes policies from other states. The information in these national schemes can be used to assist in the development of a national diabetes program in Luxembourg. Seven national diabetes programs, from The Netherlands, England, Austria, Germany, France, Belgium and Canada, were analyzed. We aimed to identify the most important principles underlying these programs and what makes them successful. The national health policies encompass 3 dimensions: psychological, social and economic. Some key determinants were identified. The most successful diabetes programs promote quality of care and services, early detection and the autonomy of people through the patient's therapeutic education. Other identified determinants are the establishment of an efficient information system, enabling people with diabetes to have access to excellent services and educational information. The system also allows health professionals to easily follow up their diabetes patients and provides a tool for evaluating and developing multidisciplinary competences for professionals.

Entities:  

Mesh:

Year:  2011        PMID: 21786738

Source DB:  PubMed          Journal:  Sante Publique        ISSN: 0995-3914            Impact factor:   0.203


  2 in total

Review 1.  Many diseases, one model of care?

Authors:  Tit Albreht; Mariana Dyakova; François G Schellevis; Stephan Van den Broucke
Journal:  J Comorb       Date:  2016-02-17

2.  State of Diabetes Self-Management Education in the European Union Member States and Non-EU Countries: The Diabetes Literacy Project.

Authors:  Henna Riemenschneider; Sarama Saha; Stephan van den Broucke; Helle Terkildsen Maindal; Gerardine Doyle; Diane Levin-Zamir; Ingrid Muller; Kristin Ganahl; Kristine Sørensen; Peter Chang; Dean Schillinger; Peter E H Schwarz; Gabriele Müller
Journal:  J Diabetes Res       Date:  2018-04-17       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.